Michail Maraslis has worked for a number of organizations since 2017. In 2017, they were a Research Assistant at Universität Konstanz. In 2018, they were a Research Intern at both Sahlgrenska Academy at University of Gothenburg and University of Bergen/Haukeland University Hospital. In 2019, they completed a Master Thesis at Biotechnologie Institut Thurgau an der Universität Konstanz. In 2020, they were a Research Assistant at the same organization. Currently, they are a Research Associate II - Preclinical Pharmacology & Biomarker Development and Research Associate - Preclinical Pharmacology & Biomarker Development at iOmx Therapeutics AG.
Michail Maraslis completed a Bachelor of Science (BS) in Biological Sciences at the University of Konstanz between 2013 and 2016. Michail then went on to pursue a Master of Science (MS) in Biological Sciences, Disease Biology at the same university, graduating in 2020. In 2017-2018, they also completed an MS in Molecular Biology at the University of Gothenburg. Most recently, they completed Free Studies in Bioentrepreneurship at Karolinska Institutet in 2020.
April 1, 2024 - present
April, 2022
March, 2021
Senior Research Associate at Institute for Advanced Sustainability Studies (IASS)
Senior Research Associate at Juvena Therapeutics
Senior Research Associate at Juvena Therapeutics
Senior Research Associate at PrognomiQ
Senior Research Associate at IOmx Therapeutics